皇家华人

header-logo
GettyImages-609179959-hero
headshot

Mary Eapen, MRCPI, MS, MBBS

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English

Education

  • MRCPI - Gen Med Royal College of Phy of Ireland
  • MS -Master of Science
  • MBBS - Doctor of Medicine

Biography

Dr. Eapen received her MBBS from Ahmadu Bello University, Zaria, Nigeria, in 1987. She completed a pediatric residency in 1997. In 2000, Dr. Eapen completed a fellowship in hematology/oncology/blood and bone marrow transplant and a MS in Clinical Research at the University of Minnesota, Minneapolis, Minnesota.

Research Interests

Mary Eapen, MD, MS, is Professor at the 皇家华人 and Senior Scientific Director - Research, Center for International Blood and Marrow Transplant Research. Her research focuses on the use of graft sources other than bone marrow for allogeneic hematopoietic cell transplantation for acute leukemia and marrow failure disorders.

Publications

  • (John TD, Walters MC, Rangarajan HG, Rahim MQ, McKinney C, Bollard CM, Abusin G, Eapen M, Kassim AA, DeBaun MR.) Blood Adv. 2024 Dec 10;8(23):6055-6063 PMID: 39374573 PMCID: PMC11635641 10/08/2024

  • (Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier CD, Jaroscak JJ, Bergmann S, Wong TE, Kota VK, Pace BS, Lekakis LJ, Lulla PD, Nickel R, Kasow KA, Popat UR, Smith WR, Yu LC, DiFronzo NL, Geller NL, Kamani N, Klings ES, Hassell K, Mendizabal AM, Sullivan K, Neuberg DS, Krishnamurti L.) Blood Adv. 2024 Oct 29 PMID: 39471440 10/29/2024

  • (Eapen M.) Blood. 2024 Oct 03;144(14):1469-1470 PMID: 39361302 SCOPUS ID: 2-s2.0-85204711177 10/03/2024

  • (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ.) EClinicalMedicine. 2024 Oct;76:102819 PMID: 39290639 PMCID: PMC11405822 09/18/2024

  • (Eapen M.) Blood. 2024 Jul 18;144(3):248-249 PMID: 39023876 SCOPUS ID: 2-s2.0-85198150047 07/18/2024

  • (Eapen M.) Haematologica. 2024 Jul 01;109(7):2024-2025 PMID: 38946648 PMCID: PMC11215355 SCOPUS ID: 2-s2.0-85197633211 07/01/2024

  • (Graff Z, Wachter F, Eapen M, Lehmann L, Cooper T.) Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e438690 PMID: 38862135 06/12/2024

  • (Brazauskas R, Eapen M, Wang T.) Best Pract Res Clin Haematol. 2024 Mar;37(1):101540 PMID: 38490768 SCOPUS ID: 2-s2.0-85185562266 03/16/2024

  • (Eapen M.) Blood. 3 October 2024;144(14):1469-1470 SCOPUS ID: 2-s2.0-85204711177 10/03/2024

  • (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ.) eClinicalMedicine. October 2024;76 SCOPUS ID: 2-s2.0-85202953543 10/01/2024

  • (Eapen M.) Blood. 18 July 2024;144(3):248-249 SCOPUS ID: 2-s2.0-85198150047 07/18/2024

  • (Brazauskas R, Eapen M, Wang T.) Best Practice and Research: Clinical Haematology. March 2024;37(1) SCOPUS ID: 2-s2.0-85185562266 03/01/2024

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.